SSG
TRIL

Summit Securities Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Summit Securities Group’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Hold
0
– – – 589
2021
Q3 		– Hold
0
– – – 547